At a glance
ClinicalIndex Comparison RecordN/ACompleted· 1,116 enrolled
Drug / intervention
ICD +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A DANish Randomized, Controlled, Multicenter Study to Assess the Efficacy of Implantable Cardioverter Defibrillator in Patients With Non-ischemic Systolic Heart Failure on Mortality. The DANISH Study
In Brief
A clinical study evaluating ICD and Optimal medical treatment for Heart Failure and 2 related conditions. Completed, enrolled 1,116 participants across 1 site.
Detailed Summary
The primary objective of this study is to determine the efficacy of ICD therapy compared with control on the endpoint of death from any cause in patients with heart failure of non-ischemic oetiology.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Failure, Dilated Cardiomyopathy, Reduced LVEF
CountriesDenmark
CollaboratorsDanish Heart Foundation
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 2007
Enrollment StartMar 2008
Primary CompletionJun 2016
TodayJul 2026
First PostedOct 12, 2007
Enrollment StartMar 1, 2008
Primary CompletionJun 1, 2016
TodayJul 2, 2026
Enrollment to primary: 8.3 yearsPosted 18.7 years ago
Interventions
ICDdevice
Implantation of an ICD
Optimal medical treatmentother
ACE-inhibitors or ARB Beta-blocker Optional aldosterone antagonist